2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Assessment of Gait in Huntington’s disease patients using EncephaLog smartphone’s application

NI. Inbar, N. Omer, A. Bar David, N. Geva, I. Dabakarov, L. Barsky, Z. Yekutieli, N. Giladi, T. Gurevich (Tel Aviv, Israel)

Huntington’s Disease  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Assessment of Neuropsychological Outcomes Using a New Multiple Source, Constant- Current Rechargeable Deep Brain Stimulation System for the Treatment of Parkinson’s Disease – INTREPID Study

A. Tröster, R. Jain, L. Chen, I. Study Group, M. Okun (Phoenix, AZ, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Assessment of RADIAL, a tool for the diagnostic of autosomal recessive cerebellar ataxia: a prospective study

O. Gebus, M. Renaud, M. Koenig, J. Chelly, C. Tranchant, M. Anheim (Strasbourg, France)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Assessment of the risk of falls in patients with Parkinson’s disease using Time Up and Go

F. Sattolo, L. Rodrigues, L. Lima, M. Diogo, R. Guimarães (Campinas, Brazil)

Physical and Occupational Therapy  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Association analysis between SCNN1A rs10849446, SPTLC3 rs6041636 and rs627354 and Parkinson’s disease and multiple system atrophy in a large Chinese population

XJ. Gu, YP. Chen, RW. Ou, B. Cao, HF. Shang (Chengdu, China)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Association between Gait during Daily Life and Clinical Measures: Effects of Bout Length

V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)

Quality of Life  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Association of genetic polymophisms with pharmacokinetics of levodopa in South indian PD patients

R. Borgohain, T. Sd, T. Syed, V. Kutala, R. Kandadai, S. Meka, S. Tandra (Hyderabad, India)

Neuropharmacology  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Associations of Genetic, Epigenetic and Phenotypic Measures in the Dominican Republic PKAN Cohort

F. Middleton, A. Espinoza, D. Larocca, R. Ericson, M. Santana Jimenez, K. Wagner, P. Stoeter, C. Bass, C. Muniz, S. Baser (Pittsburgh, PA, USA)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Associations of microtubule associated protein tau (MAPT) H1 subhaplotypes and the MAPT H2 haplotype with demographic and clinical features in Parkinson`s disease

A. Deutschlander, M. Heckman, T. Konno, M. Ossi, N. Diehl, A. Soto, A. Strongosky, R. Uitti, J. van Gerpen, O. Ross, W. Zbigniew (Jacksonville, FL, USA)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Asymmetry of motor symptoms in patients with Parkinson’s Disease

Y. Trufanov, N. Svyrydova, V. Svistun, I. Harkava, H. Bondarenko, N. Zhhilova (Kyiv, Ukraine)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3